Consensus AtriCure, Inc.

Equities

ATRC

US04963C2098

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-24 pm EDT			5-day change	1st Jan Change
23.05 ^USD	-0.52%		-1.71%	-35.42%

Apr. 23	Oppenheimer Upgrades AtriCure to Outperform, Price Target at $32	MT
Apr. 18	AtriCure, Inc. Announces Launch of the CryoSPHERE®?+ Probe for Post-Operative Pain Management	CI

Evolution of the average Target Price on AtriCure, Inc.

Price target over the last 5 years

History of analyst recommendation changes

b8396b77eb952259f9b0bc34.V0Rcnz4BDpbvOTQHOZdhJYPSMvgimWOH5AgE_cl5C28.DxNx0wtXQKWmaQI1aN5Sc9SEWY1Fqxfxk05Lyr8vWjc_DhblBmtAyd13dQ~fc053bc65a11a94e6eba1ea7f698f4f3

Analyst Recommendations on AtriCure, Inc.

Oppenheimer Upgrades AtriCure to Outperform, Price Target at $32	Apr. 23	MT
UBS Adjusts AtriCure Price Target to $58 From $57, Maintains Buy Rating	Feb. 16	MT
Stifel Adjusts Price Target on AtriCure to $42 From $50, Maintains Buy Rating	Feb. 16	MT
Needham Adjusts Price Target on AtriCure to $46 From $44, Keeps Buy Rating	Feb. 16	MT
UBS Adjusts AtriCure Price Target to $57 From $56, Maintains Buy Rating	Jan. 22	MT
JMP Securities Initiates AtriCure With Market Outperform Rating, Price Target is $60	23-10-23	MT
UBS Initiates AtriCure With Buy Rating, Price Target is $56	23-09-29	MT
Needham Adjusts Price Target on AtriCure to $68 From $60, Maintains Buy Rating	23-07-26	MT
Needham Adjusts Price Target on AtriCure to $60 From $58, Maintains Buy Rating	23-05-03	MT
BTIG Lowers Price Target on AtriCure to $55 From $65, Maintains Buy Rating	23-02-22	MT
Stifel Adjusts Price Target on AtriCure to $48 From $55, Maintains Buy Rating	23-02-22	MT
Canaccord Genuity Adjusts Price Target on AtriCure to $74 From $81, Maintains Buy Rating	23-02-22	MT
Canaccord Genuity Adjusts Price Target on AtriCure to $81 From $67, Maintains Buy Rating	23-02-06	MT
Needham Adjusts Price Target on AtriCure to $58 From $55, Maintains Buy Rating	22-12-19	MT
Canaccord Genuity Adjusts AtriCure Price Target to $65 From $72, Maintains Buy Rating	22-11-02	MT
Needham Adjusts Price Target on AtriCure to $55 From $65, Maintains Buy Rating	22-11-02	MT
BTIG Adjusts Price Target on AtriCure to $71 From $75, Maintains Buy Rating	22-10-17	MT
Needham Adjusts AtriCure's Price Target to $65 From $55, Citing 'Peer Multiple Expansion,' Reiterates Buy Rating	22-08-03	MT
Piper Sandler Adjusts AtriCure's Price Target to $55 From $90, Reiterates Overweight Rating	22-08-03	MT
Stifel Nicolaus Adjusts AtriCure's Price Target to $50 From $70, Reiterates Buy Rating	22-07-18	MT
ANALYST RECOMMENDATIONS : Nike, Albermarle, Diageo, Reckitt Benckiser, T-Mobile US...	22-06-28
Needham Adjusts AtriCure's Price Target to $55 From $67 on Peer Multiple Compression; Buy Rating Kept	22-06-28	MT
BTIG Adjusts AtriCure's Price Target to $75 From $94, Reiterates Buy Rating	22-06-24	MT
SVB Leerink Adjusts AtriCure's Price Target to $75 from $95, Keeps Outperform Rating	22-05-04	MT
Needham Adjusts AtriCure's Price Target to $67 From $79 on Peer Multiple Compression, Reiterates Buy Rating	22-05-04	MT